Investigation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LIM-0705 in Male Subjects With Impaired Glucose Tolerance

NCT01093677 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped no subjects enrolled

Conditions

Impaired Glucose Tolerance

Interventions

DRUG: LIM-0705
DRUG: Placebo

Sponsor

Limerick BioPharma